ArticleBMC cancer2014

Investigation of HOXA9 promoter methylation as a biomarker to distinguish oral cancer patients at low risk of neck metastasis.

Kenichiro Uchida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.